Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Comment by Uknowiton Feb 03, 2020 6:05pm
47 Views
Post# 30636443

RE:RE:Interesting PR?

RE:RE:Interesting PR?

Exactly. And it won't be long until we start fulfilling that agreement. Once the Romanian facility starts producing at full output there will be lots of $ generated from there  

One thing we have to consider is the current price of isolate, particularly in the US. Last year many producers jumped on board with hopes of selling their hemp at much higher prices. They flooded the market with hemp which resulted in the current isolate pricing we see. Most, if not all, of those producers will go under due to not being able to recover their input costs or not being able to deliver due to crop failure. They took a chance and don't have the cash on hand that Stil has. I suspect we'll see a surge in isolate prices in the US this year plus the FDA getting their act together leaving a gap in CBD supply that few will be able to fill. 


Though delayed to date,  Stil will be demonstrating quarter over quarter increases in revenue of which some will be put back into development of their third facility in Poland. Add to that that they will be seeding 5000 ha starting in March which should result in product hitting the market in September or October. Hemp has a 90 day grow cycle. 


Lots of OTC CBD based products in the works too. They haven't even begun to touch this lucrative market yet. I expect 2020 will be the year for that. And don't forget tolling revenues. The revenue stream in 2020, assuming all goes well, will be far higher than expected by most. This is one where you really have to do your DD and take the time to contact the company. And realize that this company will likely never have to go back to the table for financing. They raised the $26 mil for a reason and have a well thought out plan. 

<< Previous
Bullboard Posts
Next >>